User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

3rd European - Middle East forum on cardiovascular risks

3rd European - Middle East forum on cardiovascular risks
  • Cardiometabolic
  • Hypertension
Symposium by Excemed
Friday, Nov 28 2014
Prague, Czech Republic



Event format

Workshop session


The official language of this live educational symposium is English.

Registration status

To register for this event, contact

Sara Guglielmini

Meridiano Congress International

Senior Project Manager & Team Leader

T. +


Registration fee


This fee includes:

  • Scientific sessions
  • Coffee breaks and luncheons
  • Educational materials
  • Certificate of attendance


Dear participant,

A warm welcome to all attending the symposium “3 rd European - Middle east forum on cardiovascular risks”.

We would  like  to  inform  you  that as of 28  April  2014  the name  of  our Foundation  changed  to  EXCEMED  –  Excellence  in  Medical  Education. The name change will not impact your registration status in this or any other Foundation event.

This transition marks an exciting point in the evolution of the Foundation. We are proud to have provided world-class education to thousands of healthcare professionals over the past four decades - as a result, the Foundation has become synonymous with delivery excellence and high- impact CME.

As  we  further  develop  our  scientific  and  geographical  presence  it  is important  to  us  that  our  name  accurately  reflects  the  independent nature of the education we provide; EXCEMED symbolises our enduring mission to support the best possible outcomes for patients through the medical education we offer. We take pride in our complete dedication to the provision of CME - it is our sole focus and our passion.

We wish you an inspiring and successful learning experience in Prague.


Yours Sincerely



Cardiovascular disease remains the leading cause of death around the world. The Global Burden of Disease study (Lancet 2012) estimated that 29.6% of all deaths worldwide (15 616.1 million deaths) were caused by cardiovascular disease in 2010, more than all communicable, maternal, neonatal and nutritional disorders combined, and double the number of deaths caused by cancers.

Thus treatment of major cardiovascular diseases including acute coronary syndrome, stroke or heart failure present a significant and costly challenge for health systems - without taking into consideration that the most effective therapy for these diseases is prevention based on effective control of risk factors.

Essential hypertension remains an unsolved problem in cardiovascular medicine, despite the effort of scientific societies and the large number of drugs which are now available. Most hypertensive patients are still not receiving the correct pharmacological treatment and may not have their blood pressure values suitably normalised. In addition, other risk factors, including increase in heart rate, are often not considered and this can lead to an adjunctive cardiovascular risk . It is crucial to state that there is a clear need to promote clinical management of hypertension that is derived from evidence-based medicine and scientific guidelines. Also, scientific knowledge must be  transformed into clinical practice.

EXCEMED is proud  to  organize  the  2014 "3rd European - Middle east forum on cardiovascular risks". This live educational symposium will examine recent evidence in the treatment of hypertension with a specific focus on the correct utilisation of the “old” drugs such as beta-blockers and the “new” therapeutic approaches such as renal denervation. There will also be discussions on the main hypertension- derived clinical conditions, including acute coronary syndrome and heart failure. Possible solutions will be explored through direct interaction with participants using clinical cases.

Learning objectives

By attending this live educational symposium learners will be able to:

  • Evaluate the relationship between heart rate and cardiovascular risk
  • Demonstrate effective treatment of hypertensive patients discussing specific and challenging issues related to novel  aspects in the treatment of essential hypertension
  • Discuss the relevant aspects of acute coronary syndrome treatment
  • Actively participate in the debate about the real effectiveness of renal denervation in the treatment of essential hypertension
  • Manage the complexity of the relationship of hypertension and heart failure with particular attention to the potential role of associated thyroid disease and the possible beneficial effect of pharmacological antihypertensive treatment.

Learning approach


The "3rd European - Middle east forum on cardiovascular risks"  consists of lectures, debates and workshop sessions involving  participants  in  an  interactive  clinical  case  discussion. During  the  workshops  participants  will  be  divided  between  two  breakout rooms with one iPad every three attendees. Thanks to a platform that simulates the medical decision-making process, the players will be engaged  in  a  structured  clinical  case.  At  the  end of the  workshop participants will be invited to the plenary room for a follow up and,based on selection criteria that will be explained at the beginning ofthe workshop, the best group will be rewarded.

Accreditation details

The  EXCEMED  symposium  “3rd European  -  Middle  east  forum  on cardiovascular risks” (Ref. 00003371) to be held on 28 November 2014 in Prague, Czech Republic, is accredited by the European Board for Accreditation in Cardiology (EBAC ® ) for 6 (six) CME credit hours (Day #1: 6 (six) CME credits).

EXCEMED adheres to the principles of the Good CME Practice group (gCMEp).

Scientific programme

Friday, 28 November

08.45 Welcome and Introduction
Giuseppe Mancia (Italy)


Session I Hypertension

Chairman: Renata Cifkova (Czech Republic)


9.00 Hyperternsion guidelines
Giuseppe Mancia (Italy)

09.20 Antihypertensive therapies and risk of heart failure
Sverre Kjeldsen (Norway)

09.40 Managing of acute coronary disease 
Frank Ruschitzka (Czech Republic)

10.00-10.20 Questions and Answers

10.20 – 10.45 Coffee break


Session II Clinical Updates

Chairman: Kennedy Cruickshank( UK)


10.45 – 11.45 Renal denervation Debate
Stefano Taddei (Italy) and Felix Mahfoud (Germany)

11.45 – 12.45 Interactive clinical cases workshop
Stefano Taddei (Italy) and Partner

Learners will be divided into breakout rooms with one iPad to every three attendees. Final discussion will be delivered the in plenary room.

12.45 – 13.45 Lunch


Session III Heart Failure

Chairman:  Antonio Coca (Spain)


13.50 Hypertension and risk of heart failure 
Robert Fagard (Belgium)

14.10 – 14.30 Thyroid disease and heart failure risk   
Bernadette Biondi (Italy)

14.30 – 14.50 Heart rate and cardiovascular risk  
Athanasios Manolis (Greece)

14.50 – 15.10 Questions and Answers

15.10-15.30 Coffee break


Session IV Workshops

Chairman:  Giuseppe Mancia


15.30 WS2 Interactive clinical cases workshop. 
Stefano Taddei and partner

Participants  will be divided into breakout rooms with one  iPad to every three attendees. Final discussion will be held in the plenary room. A  competition will be announced prior to the workshop start and an award will be maded to  the best group in the plenary room

16.15 Plenary room discussion and recognition of  best workshop group

16.30 Closing remarks
Giuseppe Mancia

17.00 End of the live educational symposium

CME provider

Salita di San Nicola da Tolentino, 1/b

00187 Rome, Italy

Programme Manager: Simona Gaudiosi

Tel.: +39 (0)6 420 413 308

Fax: +39 (0)6 420 413 677


Medical Advisor: Professor Stefano Taddei

EXCEMEDis a Swiss Foundation with headquarters in 14, Rue du Rhône, 1204 Geneva, Switzerland


Giuseppe Mancia

Department of Clinical Medicine
University of Milano-Bicocca
Milan, Italy


Bernadette Biondi
Endocrinology Unit

University Federico II di Napoli

Naples, Italy

Renata Cifkova

Department of Preventive Cardiology

Thomayer Teaching Hospital

Prague, Czech Republic

Antonio Coca

Hypertension Unit  

Hospital Clinic

School of Medicine at the University of Barcelona

Barcelona, Spain

Kennedy Cruickshank
Diabetes & Nutritional Sciences Division

King's College London 

London, UK

Robert Fagard
Hypertension and Cardiovascular Rehabilitation Unit

KU Leuven University

Leuven, Belgium

Sverre Kjeldsen
Department of Cardiology

Oslo University Hospital

Ullevål, Norway

Felix Mahfoud
Cardiology Unit

Universitätsklinikum des Saarlandes

Homburg, Germany

Giuseppe Mancia
University of Milano Bicocca

Istituto Auxologico Italiano IRCCS and 

Centro di Fisiologia Clinica e Ipertensione 

Milan, Italy

Athanasios Manolis
Cardiology Department

Asklepeion Hospital 

Athens, Greece

Frank Ruschitzka
Heart Failure and Transplantation Clinic

Zürich University Hospital

Zürich, Switzerland

Stefano Taddei
Department of Clinical and Experimental Medicine

University of Pisa

Pisa, Italy


Meridiano Congress International
Sara Guglielmini

Senior Project Manager & Team Leader

T. +